Logo image of NBVA.CA

NUBEVA TECHNOLOGIES LTD (NBVA.CA) Stock Fundamental Analysis

Canada - TSX-V:NBVA - CA67021Y1097 - Common Stock

0.22 CAD
-0.05 (-16.98%)
Last: 10/14/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, NBVA scores 2 out of 10 in our fundamental rating. NBVA was compared to 62 industry peers in the Software industry. While NBVA seems to be doing ok healthwise, there are quite some concerns on its profitability. NBVA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NBVA has reported negative net income.
NBVA had a negative operating cash flow in the past year.
In the past 5 years NBVA always reported negative net income.
In the past 5 years NBVA always reported negative operating cash flow.
NBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFNBVA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -23.61%, NBVA is doing worse than 67.74% of the companies in the same industry.
Looking at the Return On Equity, with a value of -27.80%, NBVA is in line with its industry, outperforming 41.94% of the companies in the same industry.
Industry RankSector Rank
ROA -23.61%
ROE -27.8%
ROIC N/A
ROA(3y)-19.88%
ROA(5y)-31.88%
ROE(3y)-22.65%
ROE(5y)-35.41%
ROIC(3y)N/A
ROIC(5y)N/A
NBVA.CA Yearly ROA, ROE, ROICNBVA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

NBVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NBVA.CA Yearly Profit, Operating, Gross MarginsNBVA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 -500 -1K -1.5K -2K

More info and screens

6

2. Health

2.1 Basic Checks

NBVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NBVA has about the same amount of shares outstanding.
Compared to 5 years ago, NBVA has more shares outstanding
Compared to 1 year ago, NBVA has an improved debt to assets ratio.
NBVA.CA Yearly Shares OutstandingNBVA.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NBVA.CA Yearly Total Debt VS Total AssetsNBVA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

2.2 Solvency

NBVA has an Altman-Z score of 6.03. This indicates that NBVA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NBVA (6.03) is better than 74.19% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NBVA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, NBVA belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.03
ROIC/WACCN/A
WACC11.25%
NBVA.CA Yearly LT Debt VS Equity VS FCFNBVA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M

2.3 Liquidity

NBVA has a Current Ratio of 6.77. This indicates that NBVA is financially healthy and has no problem in meeting its short term obligations.
NBVA has a Current ratio of 6.77. This is amongst the best in the industry. NBVA outperforms 91.94% of its industry peers.
A Quick Ratio of 6.77 indicates that NBVA has no problem at all paying its short term obligations.
NBVA has a better Quick ratio (6.77) than 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 6.77
Quick Ratio 6.77
NBVA.CA Yearly Current Assets VS Current LiabilitesNBVA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M

More info and screens

2

3. Growth

3.1 Past

NBVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -283.87%.
Looking at the last year, NBVA shows a very negative growth in Revenue. The Revenue has decreased by -70.56% in the last year.
NBVA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.46% yearly.
EPS 1Y (TTM)-283.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-70.56%
Revenue growth 3Y31.08%
Revenue growth 5Y27.46%
Sales Q2Q%-63.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBVA.CA Yearly Revenue VS EstimatesNBVA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M
NBVA.CA Yearly EPS VS EstimatesNBVA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 -0.01 -0.02 -0.03 -0.04

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NBVA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBVA.CA Price Earnings VS Forward Price EarningsNBVA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NBVA.CA Per share dataNBVA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUBEVA TECHNOLOGIES LTD

TSX-V:NBVA (10/14/2025, 7:00:00 PM)

0.22

-0.05 (-16.98%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-26 2025-09-26
Earnings (Next)12-22 2025-12-22
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.48%
Ins Owner ChangeN/A
Market Cap15.44M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 34.76
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB 3.69
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.01
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.61%
ROE -27.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-19.88%
ROA(5y)-31.88%
ROE(3y)-22.65%
ROE(5y)-35.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 109.38%
Cap/Sales 1.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.77
Quick Ratio 6.77
Altman-Z 6.03
F-Score1
WACC11.25%
ROIC/WACCN/A
Cap/Depr(3y)205.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-283.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-70.56%
Revenue growth 3Y31.08%
Revenue growth 5Y27.46%
Sales Q2Q%-63.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-174.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-173.56%
OCF growth 3YN/A
OCF growth 5YN/A